Back to NBIX
Linden Thomas Advisory Services, LLC → NBIX
Linden Thomas Advisory Services, LLC NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
5
Latest value
$2.6M
Q3 2026
Peak value
$3.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $961K |
| Q4 2025 | $966K |
| Q1 2026 | $983K |
| Q2 2026 | $3.1M |
| Q3 2026 | $2.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.6M | 18.5K | — | — |
| Q2 2026 | $3.1M | 18.7K | — | — |
| Q1 2026 | $983K | 7.5K | — | — |
| Q4 2025 | $966K | 6.8K | — | — |
| Q3 2025 | $961K | 6.8K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M